| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -23.20% | +0.32% | -23.52% | -23.52% | — |
| 14d | 2 | +100.00% | -20.26% | -0.34% | -19.91% | -19.91% | — |
| 30d | 2 | +100.00% | -36.69% | -0.12% | -36.57% | -36.57% | — |
| 60d | 2 | +100.00% | -44.55% | +0.43% | -44.99% | -44.99% | — |
| 90d | 2 | +100.00% | -50.10% | +1.40% | -51.50% | -51.50% | — |
| 180d | 2(1 pending) | +100.00% | -62.91% | +10.54% | -73.46% | -73.46% | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LYRA LYRA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 769 | $3.36 | $2.6K | 518,547 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 684 | $8.91 | $6.1K | 519,316 | Jul 10, 2025 | Jul 14, 2025 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 420,000 | — | — | 520,000 | Jan 8, 2025 | Jan 10, 2025 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Oct 16, 2024 | Oct 18, 2024 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 200,000 | — | — | 200,000 | Jan 30, 2024 | Feb 1, 2024 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 140,000 | Jan 31, 2023 | Feb 2, 2023 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 15,605 | — | — | 15,605 | Feb 12, 2022 | Feb 15, 2022 ↗ | View → |
| LYRA LYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 104,000 | — | — | 104,000 | Sep 13, 2021 | Sep 15, 2021 ↗ | View → |